Remdesivir for COVID-19: Beth Israel Deaconess Medical Center launches clinical trials
by Press Release from Outbreak News Today on (#516PG)
Physician-scientists at Beth Israel Deaconess Medical Center (BIDMC) are now enrolling patients in two clinical trials testing treatment options for COVID-19, the illness caused by the novel coronavirus. Two trials, led by infectious disease specialist Kathryn Stephenson, MD, MPH, will test the antiviral drug remdesivir for safety and efficacy against the respiratory infection that has ["]
The post Remdesivir for COVID-19: Beth Israel Deaconess Medical Center launches clinical trials appeared first on Outbreak News Today.